Worthington Industries, CarMax And Other Big Losers From Thursday
U.S. stocks closed lower with the Nasdaq Composite dropping more than 300 points on Thursday. Here is the list of some big stocks recording losses in the previous session.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
What 8 Analyst Ratings Have To Say About Altice USA
Within the last quarter, Altice USA (NYSE:ATUS) has observed the following analyst ratings:
Goldman Sachs Maintains Buy on Altice USA, Lowers Price Target to $10
Goldman Sachs analyst Brett Feldman maintains Altice USA (NYSE:ATUS) with a Buy and lowers the price target from $13 to $10.
Analyst Ratings for Altice USA
Analysts have provided the following ratings for Altice USA (NYSE:ATUS) within the last quarter:
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
New Street Research Upgrades Altice USA to Buy, Announces $15 Price Target
New Street Research analyst Jonathan Chaplin upgrades Altice USA (NYSE:ATUS) from Neutral to Buy and announces $15 price target.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.